Scientific Evidence

We are presenting at the 2024 American Association of Endocrine Sugeons Annual Meeting - Dallas, TX April 20-22, 2024 - Come see us!

A clinically useful and biologically informative genomic classifier for papillary thyroid cancer [2023]

Improved Risk Stratification for Papillary Thyroid Cancer (PTC) using a genomic classifier informed by clinical features [2022]

Molecular subgroups identified by machine learning enable accurate prognostication of papillary thyroid cancer [2021]

The Technological Drivers Powering Precision Oncology

Unique Thyroid Cancer Tests: New Hope Unveiled

Understanding Radioactive Iodine Resistance in Thyroid Cancer: Overcoming Treatment Challenges

Radioactive Iodine Therapy: A Precision Weapon against Thyroid Cancer

Radiofrequency Ablation: An Alternative Approach to Treating Papillary Thyroid Cancer

A clinically useful and biologically informative genomic classifier for papillary thyroid cancer [2023]

Subscribe For Updates on Testing & Diagnostics

Sign up to receive updates from Qualisure regarding our latest developments in precision medicine tools.

First Name

Last Name

Email Address

Telephone

Organization

Country

I am a(n)

consent_sub

I consent to the use of my personal information for the purpose of receiving updates and communications about the latest developments in Precision Oncology.

Get Started

Thyroid GuidePx®

News

Investors